From the Boston Biomedical Research Institute,
Watertown, Massachusetts 02472, § Department of Chemistry
and Chemical Biology, Harvard University, Cambridge, Massachusetts
02138, and ¶ Department of Biological Chemistry and Molecular
Pharmacology, Harvard Medical School, Boston, Massachusetts 02115
Received for publication, December 11, 2000, and in revised form, January 10, 2001
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Protein splicing involves the
self-catalyzed excision of a protein-splicing element, the intein, from
flanking polypeptides, the exteins, which are concomitantly joined by a
peptide bond. Taking advantage of recently developed in
vitro systems in which protein splicing occurs in
trans to assay for protein-splicing inhibitors, we
discovered that low concentrations of Zn2+ inhibited
splicing mediated both by the RecA intein from Mycobacterium tuberculosis and by the naturally split DnaE intein from
Synechocystis sp. PCC6803. Inhibition by Zn2+
was also observed with a cis-splicing system involving the
RecA intein. In all experimental systems used, inhibition by
Zn2+ could be completely reversed by the addition of EDTA.
Zinc ion also inhibited hydroxylamine-dependent N-terminal
cleavage of the RecA intein. All other divalent transition metal ions
tested were less effective as inhibitors than Zn2+. The
reversible inhibition by Zn2+ should be useful in studies
of the mechanism of protein splicing and allow structural studies of
unmodified protein-splicing precursors.
Protein splicing involves the excision of an intervening
polypeptide sequence, the intein, from a precursor protein and the concomitant joining of the flanking polypeptides, the exteins, by a
peptide bond (see Ref. 1 for a recent review of protein splicing). The
in vitro biochemical study of protein splicing has been
hampered by the fact that it is a self-catalyzed process that requires
neither accessory proteins nor cofactors (2) and therefore proceeds
rapidly under physiological conditions without the accumulation of
intermediates. However, recent progress in the molecular dissection of
inteins has made possible the expression of intein segments as fusion
proteins that undergo protein splicing in trans after
reconstitution in vitro (3, 4). This advance as well as the
recent discovery of a naturally occurring trans-splicing system (5, 6) has opened the way for the in vitro
characterization of the protein-splicing process.
Protein splicing in trans requires the reassociation of an
N-terminal and C-terminal fragment of an intein (N-intein and C-intein, respectively), each fused to an appropriate extein. Upon
reassociation, the intein fragments form a functional protein-splicing
active center, which mediates the formation of a peptide bond between the exteins, coupled to the excision of the N- and C-inteins (Fig. 1). In the experiments described in this
paper, we used two different in vitro trans-splicing
systems. The first was derived from the Mycobacterium
tuberculosis RecA intein. It consisted of a 105-residue N-intein
fused to Escherichia coli maltose-binding protein
(MBP)1 as the N-extein and a
107-residue C-intein fused to a polypeptide terminated with a His tag
as the C-extein (4). The functional reassociation of the RecA intein
segments requires prior denaturation and joint renaturation (4), even
if the C-intein is replaced by a polypeptide as short as 35 amino acid
residues (7). The second trans-splicing system was based on
the naturally split DnaE intein of Synechocystis sp. PCC6803
(8), which has a 123-residue N-intein and a 36-residue C-intein and can
undergo reassociation without prior denaturation (6). For the purpose
of these studies, we fused the DnaE N-intein, joined to the 16 C-terminal residues of the natural N-extein, to E. coli MBP
and a synthetic C-intein fused to the 5 N-terminal residues of the
natural C-extein, followed by a His tag.
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
View larger version (18K):
[in a new window]
Fig. 1.
Schematic illustration of trans
protein splicing. The gray lines represent the
exteins, and the solid black lines represent the intein
segments. The light dotted lines indicate interactions
between the two intein segments. Intein and extein segments are not
shown to scale.
A recent crystallographic study of a Saccharomyces
cerevisiae VMA intein analog fused to short extein segments
revealed that the intein contains a bound zinc ion (9). We decided to
explore the effects of zinc ion on protein splicing using the
experimental systems described above and discovered that zinc ion acts
as a general and reversible inhibitor of protein splicing. No inhibitor of protein splicing had been available until now, and the reversible inhibition by Zn2+ therefore provides a valuable tool for
the study of the mechanism of protein splicing and intein structure.
![]() |
EXPERIMENTAL PROCEDURES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Plasmid Preparation--
Plasmid pMSN encodes
MSN
, an in-frame fusion of the E. coli MBP
with the 16 C-terminal extein residues and the 123 intein residues of
the N-terminal DnaE fragment of Synechocystis sp. PCC6803.
The corresponding segment of the N-terminal dnaE fragment
was amplified by polymerase chain reaction from genomic DNA, which had
been isolated from Synechocystis sp. PCC6803 (obtained from
the American Type Culture Collection as strain 27184) as described (10)
and used to replace the six C-terminal residues of MBP and the entire
RecA intein in plasmid pMU2 s/s
6 (4). Plasmid pMSN
can thus be considered a derivative of plasmid pMal-c2x (New England
Biolabs) encoding a fusion protein in which amino acid 387 of MBP is
fused to amino acid 759 of the Ssp DnaE N-terminal fragment. Plasmid
pETUH4 encodes UC
H, which consists of the N-terminal
sequence MDPSSRS followed by the 107 C-terminal amino acids of the
M. tuberculosis RecA intein fused to a 49-amino acid
polypeptide with a C-terminal His tag, described earlier (4). Plasmid
pHU
H encodes H'U
H, which consists of the
N-terminal extein, MHHHHHHPLSG (H'), fused in-frame to the 222-residue
RecA mini-intein from plasmid pMU
5H (11),followed by a 49-amino acid
polypeptide with a C-terminal His tag (11). It was derived from
pMU
5H by replacing the coding sequence for MBP with a synthetic
oligonucleotide encoding MHHHHHHPLSG. Plasmid pMU
53H differs from
pMU
5H by mutations that led to the replacement of the Asn-Cys
sequence at the C-terminal splice junction by Ala-Ala, yielding the
fusion protein MU*
H. The intein fusion proteins encoded
by these plasmids are represented schematically in Fig. 2.
|
Protein Expression and Purification--
Plasmid-encoded
proteins were overexpressed in E. coli ER2566 (New England
Biolabs). Cultures were grown at 37 °C with shaking to a culture
density (A600) of about 0.6 and induced with 0.4 mM isopropyl-1-thio--D-galactopyranoside at
30 °C overnight, except for pHU
H, which was expressed
at 37 °C for 3 h to promote formation of inclusion bodies.
Cells were harvested by centrifugation and resuspended in buffer A (20 mM Bis-Tris-Propane, pH 7.0, 500 mM NaCl) for
MU*
H, MUN
, H'U
H, and
MSN
or buffer B (buffer A with 8 M urea) for
UC
H and disrupted by passage through a French pressure
cell. The resulting lysates were centrifuged at 15,000 × g for 30 min. For MUN
and MSN
, the lysate supernatants were passed through 0.5-ml amylose columns (New
England Biolabs) that were washed with 15 ml of buffer A and eluted
with buffer C (buffer A with 0.5 M L-arginine)
supplemented with 10 mM maltose. With H'U
H,
little expressed protein was found in the lysate supernatant, which was
therefore discarded, and the pellet was resuspended in buffer B. The
fractions containing H'U
H or UC
H in
buffer B were purified batchwise through Talon spin columns
(CLONTECH) that were washed twice with 1 ml of
buffer B and twice with 1 ml of buffer B supplemented with 10 mM imidazole and eluted with buffer C supplemented with 8 M urea and 100 mM imidazole. For
MU*
H, to obtain purified precursor protein, the lysate
was purified batchwise through a Talon spin column that was washed
twice with 1 ml of buffer A and twice with 1 ml of buffer A
supplemented with 10 mM imidazole and eluted with buffer A
supplemented with 100 mM imidazole. The eluted protein was
then passed through a 0.5-ml amylose column, washed with 15 ml of
buffer A, and eluted with 1 ml of buffer A supplemented with 10 mM maltose. Protein concentrations were estimated either by
measuring the absorbance at 280 nm or by the Bradford method (12).
Peptide Synthesis--
Peptides were synthesized and
purified as described (7). The 47-residue peptide
SCH''-A35 consists of the 36 residues of the
Synechocystis DnaE C-terminal intein, followed by the
sequence CFNKSHHHHHH. Peptide SC
H''-H35 is identical to
SC
H''-A35, except that it contains histidine at position
35 instead of alanine. Peptide UC38CA consists of the 38 C-terminal residues of the M. tuberculosis RecA intein
followed by the sequence CA. Before use, the peptides were dissolved in
buffer A, and their concentrations were estimated on the basis of their
cysteine content by the method of Ellman (13).
Reassociation and Protein-splicing Conditions--
Protein
splicing and hydroxylamine-induced cleavage mediated in
trans by the RecA intein were studied by mixing 30 µM MUN and 60 µM
UC
H in 180 µl of buffer C supplemented with 8 M urea or by mixing 20 µM MUN
and 30 µM UC38CA in 300 µl of buffer C
followed by dialysis at 4 °C for sequential 20-min periods against
50 ml each of the following buffers: buffer C supplemented with 8, 4, 2, 1, 0.5 M urea and no urea followed by overnight dialysis
at 4 °C against buffer C. All dialyses were done in the presence of
1 mM tris(2-carboxyethyl)phosphine (TCEP) and in some cases
in the presence of ZnCl2. Protein splicing was allowed to proceed at 25 °C after further addition of 1 mM TCEP and
in some cases of 10 mM EDTA or 2.0 mM
ZnCl2. Hydroxylamine-induced cleavage was studied by
incubation at 25 °C with 1 mM TCEP and 0.5 M
hydroxylamine, pH 7.0, and, when appropriate, with 10 mM
EDTA. Splicing of H'U
H was studied in a similar manner
at a protein concentration of 13 µM, and splicing
mediated by the DnaE intein segments was studied using 20 µM MSN
and 25 µM
SC
H''-H35 or SC
H''-A35 at 25 °C in the
presence of 1 mM TCEP and appropriate concentrations of
divalent metal ions or EDTA. Hydroxylamine-induced cleavage of
MU*
H was studied at a protein concentration of 3 µM by incubation at 25 °C with 1 mM TCEP,
0.5 M hydroxylamine, pH 7.0, and when appropriate, with 2.0 mM ZnCl2.
Analysis of Protein Splicing--
SDS-PAGE and densitometric
analysis by NIH Image 1.60 were performed as described previously (4),
except that in some cases, 2 mM TCEP was added to the
gel-loading buffer in place of 125 mM
DL-1,4-dithiothreitol. MALDI-TOF mass spectrometry was
performed on a Voyager RP Biospectrometry Work station
(PerkinElmer Life Sciences) as described (7). To prevent splicing
during the preparation of the renatured H'UH precursor
for mass spectroscopy, 10 mM iodoacetamide was added in the
presence of 10 mM TCEP, and the sample was incubated for 30 min at 25 °C and then dialyzed against three changes of 30 mM urea.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Effect of Zn2+ on Protein Splicing in Trans by RecA
Intein Fragments--
In the search for possible inhibitors of protein
splicing, we observed inhibition of protein splicing when
ZnCl2 was present during the reconstitution of the RecA
intein fragments and the subsequent splicing of the fusion proteins,
MUN and UC
H. The yield of spliced protein
(MH) after 16 h at 4 °C in the absence of zinc was 64% but was
reduced to 1% in the presence of 2 mM ZnCl2
(Fig. 3, lanes 1 and
2). The inhibition by ZnCl2 was almost completely reversed by incubation at 25 °C for 2.5 h in the
presence of 10 mM EDTA, whereas a similar incubation
without EDTA had little effect (Fig. 3, lanes 3 and 4).
Under similar conditions, 0.2 mM ZnCl2
inhibited protein splicing by 90%. In another experiment, the peptide
UC38CA, which does not contain a His-tag domain, was used
in place of UC
H in the splicing experiment. In this case, the yield of spliced product (M-Cys-Ala) was 53% after
reassociation at 4 °C for 16 h in the absence of zinc ion but
only 11% in the presence of 0.2 mM ZnCl2.
|
To determine whether ZnCl2 also inhibits protein splicing
when added after the reassociation of the intein fragments, we
reconstituted MUN and UC
H as above but in
the absence of both TCEP and ZnCl2. After reassociation at
4 °C for 16 h, no discernable spliced product was observed.
Upon incubation at 25 °C for 2.5 h in the presence of 1 mM TCEP, 48% splicing was observed in the absence of
Zn2+ but only 5% in the presence of 2.0 mM
ZnCl2.
To examine the ability of the Zn2+-inhibited intein to catalyze partial reactions such as hydroxylamine-dependent N-terminal cleavage, we reconstituted the trans-splicing components in the presence of 2 mM ZnCl2 and then incubated for 2.5 h at 25 °C with ZnCl2 and 0.5 M hydroxylamine, pH 7.0. N-terminal cleavage and protein splicing were almost completely suppressed, but the chelation of Zn2+ by the addition of 10 mM EDTA in a parallel incubation restored N-terminal cleavage to 54%, accompanied by 16% splicing (Fig. 3, lanes 5 and 6).
Effect of Zn2+ on cis-Protein Splicing and N-terminal
Cleavage of a RecA Mini-intein--
Generally, cis-protein
splicing cannot be studied in vitro on account of extensive
splicing of the precursor protein during in vivo expression.
However, H'UH, a fusion protein in which a 222-residue
RecA mini-intein (U
) (11) was inserted between two
His-tagged polypeptides (H' and H), was expressed in the insoluble fraction as unspliced precursor. After solubilization in 8 M urea, purification on a Talon column, and renaturation
under reducing conditions, H'U
H underwent extensive
protein splicing. Analysis by SDS-PAGE indicated 73% protein splicing
upon renaturation followed by incubation at 25 °C for 2.5 h in
the absence of ZnCl2 but no splicing in the presence of 2 mM ZnCl2. Unfortunately, owing to the small
size of the exteins, SDS-PAGE could not clearly distinguish between
protein splicing and partial reactions such as cleavage at the splice
junctions, which would yield products of a similar size. Accordingly,
we used MALDI-TOF mass spectrometry for the definitive identification
of the reaction products. Analysis of H'U
H after
renaturation and incubation in the presence of 2 mM
ZnCl2 followed by treatment with iodoacetamide to
prevent protein splicing during sample preparation for mass
spectrometry showed primarily a 30.7-kDa component (Fig.
4A), corresponding in mass to
the acetamido derivative of the precursor H'U
H (expected
Mr 30.8). When H'U
H was refolded
in the presence of ZnCl2 and then incubated for 2.5 h
at 25 °C in the presence of 10 mM EDTA, the 30-kDa
component was much reduced and replaced by a 24.0-kDa species (Fig.
4B), whose size was consistent with that of the excised
intein, U
(expected Mr 24.1).
Both samples also contained small amounts of a 25-kDa component, which
could be the product of C-terminal cleavage, H'U
(expected Mr 25.4).
|
To determine whether zinc ion can exert inhibitory effects
on a fully folded intein, we studied the inhibition by zinc of hydroxylamine-dependent N-terminal cleavage of
MU*H. MU*
H contains U*
, an
intein in which the second and third steps of protein splicing,
transesterification and asparagine cyclization, are blocked by
replacing the residues Asn-Cys at the C-terminal splice junction with
Ala-Ala. MU*
H was purified under native conditions by
affinity chromatography (Fig. 5,
lane 1) and then incubated with 0.5 M
hydroxylamine, pH 7.0, in the presence of 1 mM TCEP alone
(Fig. 5, lane 2) or 1 mM TCEP and 2 mM ZnCl2 (Fig. 5, lane 3). In the
absence of ZnCl2, hydroxylamine-induced N-terminal cleavage
proceeded to 41%, whereas in the presence of ZnCl2,
cleavage was only 4%.
|
In Vitro trans-Splicing System Based on the Naturally Split DnaE
Intein from Synechocystis sp. PCC6803 and the Role of the Penultimate
C-Intein Residue in Protein Splicing--
In contrast to the fragments
derived from the M. tuberculosis RecA intein, whose
functional reconstitution requires prior denaturation and renaturation,
the naturally split DnaE intein from Synechocystis sp.
PCC6803 reconstitutes without the need for prior unfolding (6). An
interesting aspect of the Synechocystis sp. PCC6803 DnaE
intein is that the canonical His adjacent to the intein C terminus,
which is a potential metal ligand (9), is replaced by Ala (8). Although
in vitro protein splicing was previously observed both with
the wild-type (Ala-35) C-terminal intein segment (6) and with a mutant
(His-35) C-terminal intein segment in which Ala-35 was replaced by His
(14), these studies were done in very different contexts, and it is
therefore not possible to compare the splicing efficacy of the two
intein variants. For the direct comparison of their splicing
efficiencies, we synthesized both forms of the Synechocystis
DnaE C-intein segment fused to the five N-terminal residues of the DnaE
C-extein followed by a His tag (SCH''-A35 and
SC
H''-H35). Using an N-intein segment fused to MBP as
the trans-splicing partner (MSN
), the extent
of protein splicing after 16 h at pH 7.0 and 25 °C was 48%
with SC
H''-A35 and 46% with SC
H''-H35
(Fig. 6), indicating that the penultimate
C-intein residue does not play a crucial role in protein splicing
involving the DnaE intein.
|
Effect of Zn2+ on Protein Splicing in trans by
Wild-type and Mutant DnaE Intein Segments--
Protein splicing in
trans by the DnaE split intein was also strongly inhibited
by ZnCl2, with 80% inhibition at 0.2 mM
ZnCl2 for both SCH''-A35 and
SC
H''-H35 (Fig. 7).
Zn2+ was the most effective of the divalent transition
metals ions tested followed by Cd2+, whereas
Co2+ and Ni2+ were less inhibitory, and
Mg2+ had no significant effect (Table
I).
|
|
The reversibility of the effect of Zn2+ on trans
protein splicing by the DnaE split intein was examined by incubating
the intein segments with 2 mM ZnCl2 for
16.5 h at 25 °C. Under these conditions, protein splicing with
the SCH''-A35 and SC
H''-H35 C-inteins in
this experiment was inhibited 98 and 100%, respectively. Continued incubation at 25 °C for 20 h after the addition of 10 mM EDTA led to a significant level of protein splicing (83 and 94% of the amount expected in the absence of ZnCl2 for
SC
H''-A35 and SC
H''-H35, respectively),
indicating almost complete reversal of Zn2+ inhibition.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Studies of the action of inhibitors on enzyme-catalyzed reactions have made important contributions to our understanding of enzyme mechanisms. This paper describes the first example of a general, reversible inhibitor of protein splicing. Relatively low concentrations of Zn2+ inhibited protein splicing mediated in trans by reconstituted fragments of the M. tuberculosis RecA intein (Fig. 3) and in cis by a RecA mini-intein (Fig. 4). Low concentrations of Zn2+ also inhibited hydroxylamine-induced N-terminal cleavage mediated in cis by a native RecA mutant mini-intein (Fig. 5) and in trans by reconstituted fragments of the RecA intein (Fig. 3). In all cases, the entire homing endonuclease domain had been deleted, eliminating it as a possible target for Zn2+ inhibition. Inhibition of protein splicing mediated in trans by a RecA intein reconstituted with a synthetic peptide lacking a His tag as the C-terminal fragment shows that not more than the 38 C-terminal intein residues are required for Zn2+ inhibition and that a His tag is not required. Inhibition of protein splicing by Zn2+ in a similar concentration range was also observed with the naturally split Synechocystis sp. PCC6803 DnaE intein (Fig. 7, Table I). The inhibition by Zn2+ of protein splicing mediated by two unrelated and quite different inteins suggests that Zn2+ may well be a general inhibitor of protein splicing.
The two trans-splicing systems employed for the in vitro study of Zn2+ inhibition were to some extent complementary. The RecA system is a more efficient protein-splicing system and is more versatile in that protein splicing depends less on the presence of adjacent natural extein amino acids than does the DnaE intein (6). However, its use is complicated by the need to reconstitute the intein by prior denaturation and renaturation. In this investigation, the RecA intein served as a useful system for comparing the inhibition of protein splicing with the inhibition of its first step, N-terminal cleavage, and for studying the reversibility of Zn2+ inhibition. On the other hand, the DnaE split intein system can be reconstituted without prior denaturation. This attribute greatly facilitated the systematic study of protein-splicing inhibitors such as the response to varying Zn2+ concentrations and the study of metal ion specificity. In addition, the DnaE system provides some insights into the role of the canonical His residue at the penultimate position at the intein C terminus, which has an Ala residue in its place (8). Our results indicated that the extent of protein splicing and the susceptibility to Zn2+ inhibition are similar with Ala or His as the penultimate residue of the DnaE C-intein (Figs. 6 and 7).
The inhibition by Zn2+ occurred at relatively low concentrations. Both the cis- and trans-splicing systems using the RecA intein were essentially completely inhibited by 2 mM ZnCl2 (Figs. 3 and 4), and the trans-splicing system was essentially completely inhibited by 200 µM ZnCl2 as well (cis splicing was not studied at lower Zn2+ concentrations). The range of Zn2+ concentrations that affected protein splicing in vitro is similar to the concentration range in which Zn2+ modulates the activity of some E. coli enzymes, such as succinate oxidase (15), aminolevulinate dehydratase (16), and the YyrR phosphatase (17). It should be noted that all studies reported in this paper were carried out with TCEP rather than DL-1,4-dithiothreitol as the thiol reductant, thereby avoiding complications caused by the binding of Zn2+ to the added thiol.
The specificity of metal ion inhibition was studied in the DnaE
trans-splicing system. Zn2+ was a significantly
more potent inhibitor than other divalent transition metal ions (Table
I). The presence of 2 mM ZnCl2 inhibited protein splicing by almost 90%. Cadmium ion was only slightly less
effective an inhibitor as Zn2+, which is not surprising
considering that cadmium has been shown to substitute functionally for
zinc in other enzymes, such as carboxypeptidase (18) and -lactamase
(19). The only nontransition metal studied, Mg2+, had no
significant effect on protein splicing. The absence of an effect of
Mg2+ and the fact that protein splicing occurs effectively
in vitro with intein components routinely refolded using
buffers supplemented with 1 mM EDTA (4, 7) suggest that
divalent metal ions do not play an essential role as cofactors in the
protein-splicing reaction or as structural components of inteins. It is
therefore unlikely that the inhibition by Zn2+ involves
competition with a natural divalent metal ion cofactor or prosthetic group.
The RecA intein was used to study the mode of zinc inhibition. Splicing was essentially completely inhibited by 2 mM ZnCl2, and this inhibition was fully reversible upon the addition of 10 mM EDTA for 2.5 h at 25 °C (Fig. 3). If inhibition by Zn2+ involved the replacement of a tightly bound, essential metal ion, the addition of EDTA in the absence of the essential metal would not be able to effect its reversal. The first step of protein splicing, which can be assayed independently of subsequent steps by measuring the hydroxylamine-dependent N-terminal cleavage reaction (20, 21), was also completely inhibited by 2 mM Zn2+ in an EDTA-reversible manner in the trans-splicing system (Fig. 3). The initial step in protein splicing can also be studied in a cis-splicing system by using a mutant intein in which the Asn and Cys residues flanking the C-terminal splice junction, which are essential for steps 3 and 2 of protein splicing (for a recent review, see Ref. 1), have been replaced by Ala residues. Using such a mutant intein, the hydroxylamine-dependent reaction was more than 90% inhibited by 2 mM ZnCl2 (Fig. 5). These observations indicate that Zn2+ is a reversible inhibitor of protein splicing as well as of the initial N-S acyl rearrangement, the first step in protein splicing.
Since protein splicing in trans also requires prior reconstitution of the intein segments, one could argue that Zn2+ interferes with the reassociation process rather than with protein splicing per se. At least two lines of evidence support the notion that Zn2+ inhibits protein splicing directly. (i) Protein splicing in trans can be measured independently from reassociation by carrying out reconstitution in the absence of a thiol reductant, which leads to the formation of a disulfide-linked dimer that can undergo splicing in the presence of TCEP (4). The observation that subsequent TCEP-dependent protein splicing was inhibited by Zn2+ implies that the metal ion does not need to be present during intein refolding and assembly to exert its inhibitory effect. (ii) Unspliced precursor proteins involving the RecA intein, in which the second and third steps of the protein-splicing process, i.e. transesterification and Asn cyclization (see Fig. 4 of Ref. 1), are blocked owing to mutation of the amino acid residues flanking the C-terminal splice junction, can be isolated in the native state and used to study the first step of protein splicing in terms of hydroxylamine-dependent cleavage at the N-terminal splice junction (21). The observation that hydroxylamine-dependent cleavage of a fully folded mutant intein is inhibited by Zn2+ (Fig. 5) demonstrates that the metal ion directly interferes with the first step of protein splicing.
A recent crystallographic analysis of the VMA intein of S. cerevisiae revealed a zinc ion chelated by the Cys at the C-terminal splice junction, the His residue adjacent to the intein C terminus, the Glu at position 80 in domain B, and a solvent water molecule (9). The relationship of this Zn2+ complex to the inhibition of protein splicing by Zn2+ described in this paper is not clear. It is worth noting that the effect of Zn2+ on protein splicing mediated by the DnaE intein segments was not significantly affected by the absence or presence of His adjacent to the intein C terminus (Fig. 7). Also, the inhibition by Zn2+ of the first step of protein splicing occurred in a RecA intein in which the Asn and Cys residues at the C-terminal splice junction were replaced by Ala. These observations suggest that the modes of Zn2+ binding that exert inhibitory effects of Zn2+ on the DnaE and the RecA inteins may not be the same as the mode of binding described by Poland et. al. (9).
The results presented in this paper constitute the first description of
an inhibitor of protein splicing. The inhibition of protein splicing by
Zn2+ may be a relatively general phenomenon, as it is
observed with two quite different inteins regardless of whether protein
splicing occurred in cis or trans. The complete
reversibility of this potent inhibition should make it a valuable tool
in biochemical and biophysical studies of the mechanism of protein
splicing. For example, it may allow the crystallization of
protein-splicing precursors without the need for mutations to prevent
splicing. The modulation of protein splicing by metal ions at
concentrations only in slight molar excess over the intein
concentration suggests the possibility that metal ions also could
affect protein splicing in vivo and perhaps might even serve
as a physiological mechanism to regulate protein splicing in certain organisms.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Paul Morgan and Belinda Lew for helpful comments on the manuscript and Gina Pagani for synthesizing the peptides.
![]() |
FOOTNOTES |
---|
* This work was supported by National Institutes of Health Grant R01 GM55875 (NIGMS) (to H. P.) and by a Howard Hughes Medical Institute predoctoral fellowship (to K. V. M.). The mass spectrometer used in this work was funded by National Institutes of Health Grant RR11301 and National Science Foundation Grant 96-04781.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Boston Biomedical
Research Institute, 64 Grove St., Watertown, MA 02472-2829. Tel.:
617-658-7800; Fax: 617-972-1753; E-mail: paulus@bbri.org.
Published, JBC Papers in Press, January 10, 2001, DOI 10.1074/jbc.M011149200
![]() |
ABBREVIATIONS |
---|
The abbreviations used are:
MBP, E.
coli maltose-binding protein;
Bis-Tris-Propane, 1,3-bis-([tris(hydroxymethyl)methylamine] propane;
TCEP, tris(2-carboxyethyl) phosphine;
His tag, hexahistidine sequence;
PAGE, polyacrylamide gel electrophoresis;
MALDI-TOF, matrix-assisted laser
desorption ionization/time of flight spectroscopy;
H, a 49-amino acid
peptide with a C-terminal His tag;
H', the undecapeptide MHHHHHHPLSG;
M, N-terminal extein containing a spacer and N-terminal MBP;
UN, the 105 N-terminal amino acids of the M. tuberculosis RecA intein followed by the C-terminal sequence RGEF;
UC
, the heptapeptide sequence MDPSSRS followed by the
107 C-terminal amino acids of the M. tuberculosis RecA
intein;
U
, 222-amino acid mini-intein derived from the
M. tuberculosis RecA intein;
H'U
H, chimeric
protein consisting of the intein U
flanked by H' and H
as N- and C-exteins, respectively;
MU
H, chimeric protein
consisting of the intein U
flanked by M and H as N- and
C-exteins, respectively;
MU*
H, MU
H with
both the Asn and Cys at the C-terminal splice junction replaced by Ala;
MUN
, chimeric protein consisting of M fused to
UN
;
UC
H, chimeric protein consisting of
UC
fused to H;
UC38CA, a 40-amino acid
synthetic peptide consisting of the 38 C-terminal residues of the
M. tuberculosis RecA intein followed by the sequence CA;
SN
, 123-residue N-terminal DnaE intein segment of
Synechocystis sp. PCC6803;
MSN
, chimeric
protein consisting of M joined to the 16 C-terminal DnaE N-extein amino
acids of Synechocystis species PCC6803 fused to
SN
;
H'', the undecapeptide CFNKSHHHHHH;
SC
H'', a 47-amino acid synthetic peptide consisting of
the 36-residue sequence of the Synechocystis species PCC6803
DnaE C-terminal intein fused to H'';
SC
H''-A35, SC
H'' with the wild type alanine residue at position 35;
SC
H''-H35, SC
H'' with histidine at
position 35. The nomenclature of the fusion proteins involving intein
segments is represented schematically in Fig. 2.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. | Paulus, H. (2000) Annu. Rev. Biochem. 69, 447-496[CrossRef][Medline] [Order article via Infotrieve] |
2. | Xu, M.-Q., Southworth, M. W., Mersha, F. B., Hornstra, L. J., and Perler, F. B. (1993) Cell 75, 1371-1377[Medline] [Order article via Infotrieve] |
3. |
Southworth, M. W.,
Adam, E.,
Panne, D.,
Byer, R.,
Kautz, R.,
and Perler, F. B.
(1998)
EMBO J.
17,
918-926 |
4. | Mills, K. V., Lew, B. M., Jiang, S.-Q., and Paulus, H. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 3453-3458 |
5. | Wu, H., Xu, M.-Q., and Liu, X.-Q. (1998) Biochim. Biophys. Acta 1387, 422-432[Medline] [Order article via Infotrieve] |
6. |
Evans, T. C.,
Martin, D.,
Kolly, R.,
Panne, D.,
Sun, L.,
Ghosh, I.,
Chen, L.,
Benner, J.,
Liu, X.-Q.,
and Xu, M.-Q.
(2000)
J. Biol. Chem.
275,
9091-9094 |
7. |
Lew, B. M.,
Mills, K. V.,
and Paulus, H.
(1998)
J. Biol. Chem.
273,
15887-15890 |
8. |
Wu, H.,
Hu, Z.,
and Liu, X.-Q.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9226-9231 |
9. |
Poland, B. W.,
Xu, M.-Q.,
and Quiocho, F. A.
(2000)
J. Biol. Chem.
275,
16408-16413 |
10. | Dzelkalns, V. A., and Bogorad, L. (1986) J. Bacteriol. 165, 964-971[Medline] [Order article via Infotrieve] |
11. | Shingledecker, K., Jiang, S.-Q., and Paulus, H. (1998) Gene 207, 187-195[CrossRef][Medline] [Order article via Infotrieve] |
12. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve] |
13. | Ellman, G. L. (1959) Arch. Biochem. Biophys. 82, 70-77[Medline] [Order article via Infotrieve] |
14. |
Scott, C. P.,
Abel-Santos, E.,
Wall, M.,
Wahnon, D. C.,
and Benkovic, S. J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13638-13643 |
15. | Kasahara, M., and Anraku, Y. (1974) J. Biochem. 76, 967-976[Medline] [Order article via Infotrieve] |
16. | Spencer, P., and Jordan, P. M. (1993) Biochem. J. 290, 279-287[Medline] [Order article via Infotrieve] |
17. |
Zhao, S.,
Zhu, Q.,
and Somerville, R. L.
(2000)
J. Bacteriol.
182,
1053-1061 |
18. | Coleman, J. E., and Vallee, B. L. (1961) J. Biol. Chem. 236, 2244-2249[Medline] [Order article via Infotrieve] |
19. | Paul-Soto, R., Zeppezauer, M., Adolph, H. W., Galleni, M., Frere, J. M., Carfi, A., Dideberg, O., Wouters, J., Hemmingsen, L., and Bauer, R. (1999) Biochemistry 38, 16500-16605[CrossRef][Medline] [Order article via Infotrieve] |
20. | Shao, Y., Xu, M.-Q., and Paulus, H. (1996) Biochemistry 35, 3810-3815[CrossRef][Medline] [Order article via Infotrieve] |
21. | Shingledecker, K., Jiang, S.-Q., and Paulus, H. (2000) Arch. Biochem. Biophys. 375, 138-144[CrossRef][Medline] [Order article via Infotrieve] |